CHICAGO (Reuters) – A powerful infusion of HIV-fighting antibodies beat back a potent form of the virus in monkeys and kept it at bay for weeks, U.S. government scientists and a team led by Harvard University found, offering a potential next step in the battle against human HIV.
The two studies, published on Wednesday in the journal Nature, involve the use of rare antibodies made by 10 percent to 20 percent of people with HIV that can neutralize a wide array of strains.
HERNANDO, Mississippi (Reuters) – When Dr Michael Minor first became pastor at Oak Hill Missionary Baptist Church in Hernando, Mississippi, in 1996, he discovered a population overcome by an epidemic of obesity.
“It was so bad, I was having a funeral every weekend,” he said.
Minor took dramatic action for a Southern preacher, banning fried chicken at church potlucks and setting up a walking track around the church perimeter.
CHICAGO (Reuters) – New federal guidelines expand the range of patients who might benefit from Johnson & Johnson’s Sirturo drug for the treatment of multi-drug-resistant tuberculosis (MDR-TB), the first new type of TB drug to win U.S. regulatory approval in more than 40 years.
The recommendations, issued on Thursday by the U.S. Centers for Disease Control and Prevention, go beyond the narrow group of adults listed in the drug’s label, offering advice on use of the treatment in children, pregnant women and individuals with other health complications, such as diabetes and HIV infection.
CHICAGO (Reuters) – The kind of basic science that helped Randy Schekman win the coveted Nobel medicine prize might never have been funded if he had applied today.
Schekman, along with two other U.S.-based winners of the 2013 medicine prize, Thomas Suedhof and James Rothman, slammed recent spending cuts at the National Institutes of Health, the biggest funder of scientific research in the world. The budget curbs were undermining the chances of breakthroughs and the next generation of basic research, they said.
STOCKHOLM/CHICAGO, Oct 7 (Reuters) – Three scientists won
the Nobel medicine prize on Monday for plotting how cells
transfer vital materials such as hormones and brain chemicals to
other cells, giving insight into diseases such as Alzheimer’s,
autism and diabetes.
Americans James Rothman, 62, Randy Schekman, 64, and
German-born Thomas Suedhof, 57, separately mapped out one of the
body’s critical networks in which tiny bubbles known as vesicles
enable cells to secrete chemicals such as insulin into the
PASCAGOULA, Mississippi (Reuters) – As Americans across the nation begin to find out what Obamacare has in store for them, many of Mississippi’s most needy will find out the answer is nothing.
That is likely the case for William and Leslie Johnson of Jackson County, since the state decided not to expand the Medicaid program for the poor under President Barack Obama’s Affordable Care Act. As a result, nearly 300,000 adults there will fall through the cracks of healthcare reform.
CHICAGO/LONDON (Reuters) – In 2006 when doctors started testing a melanoma treatment made by Roche Holding AG on patients, they were used to facing slim odds – about one in eight – that the tumors would shrink on chemotherapy. This time, they couldn’t believe their eyes.
With Zelboraf, a drug that targets specific mutations in cancer cells, eight out of 10 patients in an early-stage trial experienced significant tumor shrinkage. Roche clearly had a remarkable drug, though it only worked for people with a specific genetic makeup.
CHICAGO/LONDON, Sept 26 (Reuters) – In 2006 when doctors
started testing a melanoma treatment made by Roche Holding AG on
patients, they were used to facing slim odds – about one in
eight – that the tumors would shrink on chemotherapy. This time,
they couldn’t believe their eyes.
With Zelboraf, a drug that targets specific mutations in
cancer cells, eight out of 10 patients in an early-stage trial
experienced significant tumor shrinkage. Roche clearly had a
remarkable drug, though it only worked for people with a
specific genetic makeup.
CHICAGO (Reuters) – Antibiotic-resistant gonorrhea, a diarrhea-causing superbug and a class of fast-growing killer bacteria dubbed a “nightmare” were classified as urgent public-health threats in the United States on Monday.
According to a new report by the U.S. Centers for Disease Control and Prevention (CDC), at least 2 million people in the United States develop serious bacterial infections that are resistant to one or more types of antibiotics each year, and at least 23,000 die from the infections.
CHICAGO, Sept 9 (Reuters) – U.S. states that opt to expand
Medicaid under President Barack Obama’s Affordable Care Act
(ACA) can expect to enroll new patients who are younger,
thinner, healthier, less depressed and more likely to be white
than those now covered by Medicaid, U.S. researchers said on
The latest findings add to a growing picture of the incoming
class of Medicaid enrollees under the ACA, which gives states
the option to expand their Medicaid rolls to include previously
ineligible low-income adults.